Three studies in type 2 diabetes: SERENADE The rimonabant (a blocker of the CB1 receptors) in monotherapy in type 2 diabetes

被引：0
|
作者：
Roussel, R. [1 ]
机构：
[1] CHU Bichat Claude Bernard, Serv Endocrinol Diabetol Nutr, F-75722 Paris 18, France
来源：
ANNALES D ENDOCRINOLOGIE | 2007年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S33 / S35
页数：3
相关论文
共 50 条
  • [31] Purinergic receptors activity in type 2 diabetes
    Solini, A
    Chiozzi, P
    DI Virgilio, F
    DIABETES, 2000, 49 : A335 - A336
  • [32] Outcome studies in type 2 diabetes
    Hanefeld, M
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 : S41 - S48
  • [33] The PedsQL™ in type 1 and type 2 diabetes
    Varni, JW
    Burwinkle, TM
    Jacobs, JR
    Gottschalk, M
    Kaufman, F
    Jones, KL
    DIABETES CARE, 2003, 26 (03) : 631 - 637
  • [34] Screening for type 1 and type 2 diabetes
    不详
    CANADIAN PHARMACISTS JOURNAL, 2009, 142 : S7 - S8
  • [35] Diabetes mellitus Type 1 and Type 2
    Henzen, Christoph
    Fischli, Stefan
    THERAPEUTISCHE UMSCHAU, 2020, 77 (07) : 287 - 287
  • [36] The ePedsOL™ in type 1 and type 2 diabetes
    Vami, James W.
    Limbers, Christine A.
    Burwinkle, Tasha M.
    Bryant, William P.
    Wilson, Don P.
    DIABETES CARE, 2008, 31 (04) : 672 - 677
  • [37] Developments in type 1 and type 2 diabetes
    Bloomgarden, Zachary
    JOURNAL OF DIABETES, 2021, 13 (07) : 530 - 531
  • [38] Screening for Type 1 and Type 2 Diabetes
    Ekoe, Jean-Marie
    Punthakee, Zubin
    Ransom, Thomas
    Prebtani, Ally P. H.
    Goldenberg, Ronald
    CANADIAN JOURNAL OF DIABETES, 2013, 37 : S12 - S15
  • [39] Metabolomics of Type 1 and Type 2 Diabetes
    Arneth, Borros
    Arneth, Rebekka
    Shams, Mohamed
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [40] Type 2 treatments for type 1 diabetes
    Bloomgarden, Zachary
    Ning, Guang
    JOURNAL OF DIABETES, 2016, 8 (05) : 599 - 601
12345